Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States. Bone Marrow Transplant 2023 Dec;58(12):1400-1402
Date
09/07/2023Pubmed ID
37673983Pubmed Central ID
PMC11646697DOI
10.1038/s41409-023-02102-4Scopus ID
2-s2.0-85170080925 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza AAuthors
Anita D'Souza MD Professor in the Medicine department at Medical College of WisconsinWilliam R. Drobyski MD Professor in the Medicine department at Medical College of Wisconsin
Mary Eapen MBChB, MS Professor in the Medicine department at Medical College of Wisconsin
Liliana Pezzin PhD, MS, JD Director, Professor in the Institute for Health and Humanity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
DemographyHumans
Immunotherapy, Adoptive
Multiple Myeloma
Receptors, Antigen, T-Cell
United States









